|
Volumn 37, Issue 2, 2005, Pages 912-915
|
Safety and efficacy after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium: Results of a 1-year extension study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CREATININE;
IMMUNOSUPPRESSIVE AGENT;
MYCOPHENOLIC ACID;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
ACUTE GRAFT REJECTION;
ADULT;
AGED;
BIOPSY;
BLOOD TOXICITY;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
CYTOMEGALOVIRUS INFECTION;
DIARRHEA;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
DYSPEPSIA;
FEMALE;
GASTROINTESTINAL TOXICITY;
GRAFT FAILURE;
HUMAN;
HUMAN TISSUE;
INFECTION;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LONG TERM CARE;
LYMPHOMA;
MAJOR CLINICAL STUDY;
MALE;
NAUSEA;
OPEN STUDY;
PRIORITY JOURNAL;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
SKIN CANCER;
VOMITING;
|
EID: 17844378229
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.12.048 Document Type: Conference Paper |
Times cited : (15)
|
References (4)
|